SlideShare a Scribd company logo
1 of 49
1
:: INTRODUCTION ::
• Many countries have restarted their normal
routine after covid-19 pandemic.
• While, some countries including India
struggling with third wave of covid-19.
• Third wave is out of understanding for
laymen, and may do not accept this
possibilities.
• But, this third wave is predicted on scientific
bases by scientific pannels, Medical experts
and Global leaders.
:: Pattern of Pandemic in population ::
• Pandemics tend to occur in waves, and each
wave causes a large number of cases.
• Eventually, most of the population may get
immune by Asymptomatic or Symptomatic
infections (herd immunity).
• Over a time disease may die out OR may
become endemic in the community with low
transmission rates.
• Covid is caused by SARS CoV2 RNA Virus.
This virus spreads from person to person.
• As soon as it enters in human body, it starts
process of its growth, and produce more numbers
of similar viruses.
• For that it contains RNA, on the basis of RNA it
replicates many copies of it.
:: What are waves in Pandemic?
ORIGINAL VIRUS COPY-1 COPY-2 COPY-3
[1]
5
• But, in some cases it could not produce same
copy of RNA, and it produce another type of
virus.
• This new virus is little different than the
Original virus in characteristics. Because , its
protein, spikes etc are changed.
• Such new type of virus is called VARIANT.
5
:: What are waves in Pandemic?
ORIGINAL VIRUS COPY-1 VARIANT-1 VARIANT-2
[2]
6
• The whole procedure is called mutation in
scientific terms.
• So many variants can be produce from one
original virus.
• Many types or variants are produced from
Original (SARS CoV 2 -Wuhan) virus in the
world.
• Some variants are powerful, others are weak.
Weak variants could not sustain for long time.
• Variants which are more powerful for disease
are known as variants of concern by WHO.
• There are so many vaiants of concern
identified so far; Alpha, Beta, gamma, delta
etc.
• Now a days Delta variant is in talk.
• Delta variant found in India, during second
wave, more damage caused by delta variant.
• Now delta variant is found more than 98
countries in world.
• The scientific name of delta variant is B
1.617.2
According to WHO :
• India has UK variant (Spreading in many states)
• South Africa and Brazil variants (in some states)
• Double mutant “B.1.618 ” in West Maharastra
• Triple mutant “B.1.618” in west Bangal
• There will be more due to huge turn over
In fact the second wave is due to many variants and
not due to the single variant of first wave.
8
Many variants are in India
• Recently, scientist have found changes in Delta.
The new variant of delta is K417N or Delta plus.
• So, Detla plus, may have many differnt
characteristics than Delta.
• More than 40 cases are found in India, with new
Delta plus variant.
9
Wave-2 by Delta . . Wave - 3 by ??
DELTA DELTA + DELTA +
Caused Second
WAVE
May Cause Third
WAVE ???
10
• Comparison for : Prediction for 3rd -Wave :
• 1st Delta was found in Octo 2020. It is
responsible for deadly second wave in India.
• 1st case of Delta plus found on 5th April 2021.
This variant may be cause for third wave in
India.
• The predictions of third wave are made by
following Five factors.
Comparision : Delta and Delta plus
• These five points will help to predict about third wave
11
Delta and Delta plus variant :
Transmissibility
Virulence :
1
2
Test Compliant :
3
4 Drug Compliant :
Vaccine Efficacy :
5
Delta+ is less transmissible
than delta
Ability to kill, Delta+ is less
fatal than Delta
Both identifiable with rapid
and RTPCR
Supportive drugs will work
on both; Delta and Delta +
effective on Delta, but
Delta+ reduce rate up to 30%
12
• Mutants emerge if they have transmission
advantage over predecessors.
1. A million a month vs a week tells us that all
new variants are spreading 3-4 times faster
than D614G varinat.
2. People and Government facilitated rapid
dissemination of mutant variants by giving up
on masks and physical distancing.
3. Eg. Kumbh mela (Jan -1 to April-20) and
election rallies (February through April 1st
week).
12
Why did infection spread so fast ?
13
13
• Epidemiology : Foundation Science of Public
Health
• In India, Epidemiology is used much in
Research
• Taught in Medical colleges and in schools of
public health
• Not used in health management, because there
is no Public Health Infrastructure.
• Destiny says : India Needs Public Health
13
Epidemiology : Who wants it ?
14
:: Ministry of Health ::
1 2 3 4
Dept of
Health
Services
Dept of
Family
Welfare
Dep of
Health
Research
Missing
Dept of
Public
Health
India’s Ministry of Health has a Missing
Elephant !!!!!
15
15
15
• A wave requires suffcient population
• Left – over from 1st wave (700 million) plus
65,000 births per day : so . . . . .
• 10 weeks . . . . . . Just 5 million children
• Variants with greater RO emerged, Unnoticed
• Failed to vaccinate at least 20-30 % of
population to provide immune.
• Encouraged crowding, avoid safety measures
15
Why did the Second wave emerged ? - 1
16
16
16
16
• 50% population was vulnerable after 1st wave
• Left with D614G, There would not have been
second wave, but new variants emerged.
• The group of 10 labs (INSACOG) assigned for
monitoring 5% of viruses for variant did not so
• Entry of UK, south Africa and Brazil variants
were unnoticed until 2nd wave emerged.
• Indian Mutants (B.1.617 and 618) sperad fast
in Maharastra and West Bengal
16
Why did the Second wave emerged ? - 2
Attrributes of first wave :
• Started : 06.03.2020; Peacked : 16.09.2020 (191
days)
• Pre – Peak Cases : 5,115,893,(26,785/day)
• Post-Peak Cases : 5,108,904 (49,124 / day)
• End : 28.12.2020 (104 days)
• Whole wave : 295 days (>42 weeks, ~ 10 months)
• Cases : 10,224,791 (34,660 / day)
• One Million Cases per month
Rather symmetrical of bell-shaped . .
18
18
18
18
• Started : 09.03.2021
• Peaked : 06.05.2021 (58 days; ˃ 8 weeks)
• Cases till peak : 10,240,661 (176563 / day)
• Surge volume 176,563 / 26,785 = 6.6 times
• Surge speed in days 191 / 58 = 3.3 times
• One Million per 6 days
• Time to reach million 30 / 6 = 5 times faster
18
:: Second Wave – Pre-peak Profile ::
Around 23 African countries experienced third wave of
COVID-19 as of July 13, 2021, according to CDC.
19
20
• First wave : severe disease occurred - primarily
- elderly and individuals with co-morbidities.
• Second wave : Severe disease - younger group
(30-45 years), also without co-morbidities.
• If Third wave : likely to infect remaining non-
immune individuals - include children also.
• Latest sero-survey : infected children of 10-17
years was around 25%, the same as adults.
• Children are as susceptible as adults and olders
to develop infection but not severe disease.
21
Risk : Children and third Wave
• 1st and 2nd wave make
some population
immune (herd
immunity)
• Some population
immune by vaccines
• Remaining part is
unprotected : Children
• No Vaccine > 18 yrs
22
WHY ? CHILDREN are at RISK ?
• Census :
• 41 % consist of < 18 years,
it is large number
• First wave : 1-2 %
Children affected
• Second wave : 10 %
• Third wave : ??????
• Coronaviruses can spread in
Children by :
• Parents and Elders are Major
Source (Schools closed,
children are at home only)
23
• After Second wave, sudden carelessnes by
parents, children attended all functions with
parents, gatherings etc.
• Parents do not follow themselves or force
Children for safety and precautions
TRANSMISSION:
• There are four stages for disease transmission:
• Stage 1: Imported cases:
• Disease is just introduced by traveled people .
• Stage 2: Local transmission
• Travelers spread infection : family, neighbors and friends.
• Stage 3: Community transmission
• Infection spreads in community in large areas.
• Stage 4: Widespread outbreak or Epidemic stage
• Fourth and Final stage of transmission, a widespread
outbreak - an epidemic - as the number of cases and
deaths begin rapidly multiplying, with no end in sight.
STAGES OF TRANSMISSION:
• Infection enters in body via following :
25
Portals of Entry :
NOSE : EYES :
1 2
MOUTH :
3
• Incubation Period is
varied from person to
person.
• But average incubation
period found is 2 to 15
days in recent cases.
INCUBATION PERIOD :
REPLICATION OF CORONA VIRUS ::
28
Corona Virus Enters LUNGS
Alveoli
(2 types of cells in alveoli)
Pneuomocyte
type-1
Pneumocyte
type-2
Helps for Gas
exchange
Produce
surfactant
Surfactant prevent
lung from collapse
Adhere Pneumocyte-2
( S-Protein- ACE-2
Receptor )
PATHOGENESIS OF COVID -19 :: 1
29
Entry in Cells and
replication
APC(Antigen presenting
Cell)- MHC
Cytokine Storm
Release of IL-1, IL-6 ,
TNF alpha
Vasodilatation & Increased
vascular Permeability
PATHOGENESIS OF COVID -19 :: 2
30
Alveolar edema-Surfactant Dysregulation-
Collapse of alveoli
Hypoxia- Increased
Work of Breathing
MSOF –Multi system organ failure
SIRS – Systemic
Inflammatory Response
Syndrome
PATHOGENESIS OF COVID -19 :: 3
Fever
Dry cough
Fatigue
Running nose
Body ache
Headache
Vomiting
Anosmia : In ability to smell
Ageusia : Inability to taste
Abdominal related complaints
Commom Clinical Features :
32
MILD CASES : 98%
MODERATE
CASES : 1 - 2 %
SEVERE
CASES :
0.5 - 1 %
Spectrum : Disease severity in Children :
33
• Fever, Sore throat, rhinorrhoea, Cough,
Diarrhoea, vomiting, Pain in abdomen,
• Mild : Saturation > 94,
• No tachypnoea,
• No dehydration
• Mild can be treated at home.
• Home isolation
Asymptomatic or Mild disease :
[1]
34
• Fast Breathing (age based) :
1. < 2 months : > 60 / min
2. 2-12 months : > 50/min
3. 1-5 years : > 40/min
4. > 5 years : > 30/min
• SPO2 : 90-94 %
• No signs of severe illness (systemic
involvement)
• Moderate or severe dehydration
Moderate disease (Pneumonia) :
[2]
• Pneumonia with any of the following :
1. Increased respiratory efforts (grunting, severe
retractions)
2. (if speaking) Inability to complete full
sentences
3. Cyanosis, SPO2 : less than 90 %
4. Letharty, somnolence, seizures, oliguria,
• Keywords : Mild will never convert
immediate severe, It will take time, identify it.
35
Severe illness, Severe pneumonia :
[3]
1. ARDS : (Acute Respiratory Distress
Syndrome),
2. Sepsis, Septic Shock,
3. MODS : (Multiple Organ dysfunction
Syndrome), Thrombosis,
4. MIS-C : (Multi system inflammatory
syndrome in Children)
• Hospitalization : PICU, HDU(High
Dependency Unit)
36
CRITICAL CONDITION :
• COVID Suspect case:
• Patient with ARI & or history of travel to a location of
Community Transmission in last 14 days.
• Pt with ARI & close contact with COVID pt in last 14 days
• Or a pt with severe ARI in absence of alternative diagnosis
• Probable case:
• A suspected case with Test result inconclusive
• or test could not be done yet, having some symptoms.
• Confirmed case:
• A Pt with positive COVID-19 test, even he do not have
clinical signs and symptoms present.
CLINICAL APPROACH :
1. RTPCR : If positive, do not confirm by CT
Scan
2. RTPCR : CT value (cycle threshold) : less
then 35 is significant : value, more than 35 is
not covid positive :
3. Mild symptoms, Mild covid no other
investigations required
4. CRP, D-dimer, HRCT etc should be decided
by pediatrician
DIAGNOSIS ::
1. Fever : PCM 10-15 mg/kg, repeat every 4-6
hours
2. Avoid NSAIDS (Ibuprofen, Mefenamic acid)
3. Cough suppressant : No role
4. Throat Soothing : Warm saline garlgles :
only older children, adolescents
5. Antibiotics : not indicated
6. Adequet hydration, supportive care
:: TREATMENT :: MILD DISEASE
:: TREATMENT ::
40
1. Hospitalization : NO ICU needed
2. Monitor Progress
3. Feeding, fluid to avoid dehydration, over hydration
4. Antipyretics
5. Suspicion of bacterial infection : Amoxycillin
6. SPO2 < 94 % give O2
7. Rapid progression : steroids (by pediatrician)
8. Rare cases : Remdesivir (by pediatrician)
:: TREATME MODERATE DISEASE
TREATMENT
41
1. Intensive Care, PICU
2. ARDS, Sepsis, Septic shock, MIS-C
3. Investigations, Evaluate thrombosis, HLH organ failure,
4. Steroids, Remdesivir
5. Empiric Antimicrobials
6. Oxygen therapy
7. Restricted fluid therapy
8. Ventilation
:: TREATME SEVERE DISEASE
TREATMENT
42
• Following Children will required special care.
Children : Requires Special Care :
Congenital Heart Disease
Kidney Diseases
1
2
Genetic diseases
3
4 Imminity Disorders
Metabolic disorders
5
43
:: TREATME VACCINATION :
PREVENTION
• Develope Herd Immunity before 3rd wave.
• Immune by disease or by Vaccination. First
option is uncertain and may be fatal.
Vaccination is safe and under our control.
• Before third wave : atleast 40 % population
must be vaccinated.
• But unfortunately . . . . . .
• In India 7.9 % people are fully vaccinated,
• while 20.8 % are vaccinated for first dose.
• This rate is much lower than other countries.
1. USA : 50.4 %
2. UK : 58.1 %
3. Israel : 59.5 %
4. Spain : 59.3 %
5. Canada : 60.7 %
6. India : 7.9 %
• Source : http://www.mygov.in/information/covid-19
44
Vaccination : Worlwide :: (Fully )
45
:: TREATME GENERAL MEASURES
PREVENTION
1. Above 2 years, Mask with three layers.
2. Less exposure to children, shopping, market,
functions etc.
3. frequent Hand washing habit, personal
sanitizer for them.
4. Adult, specially mothers should vaccinted,
because children needs mother.
5. Identify symptoms in Children, Consult and
follow Pediatrician.
• Managing Children is More difficult :
• Adult patient cooperate, follow instruction
etc, can left alone with oxygen mask, etc
• Children can not left alone, remove oxygen
mask, needs care taker :
• Limited Nurses, even can not sedate them
• Only parents can manage : 24 hours
• Parents sitting with them must Vaccinated !!!
46
Children : Hospitalization a Challange
• less then 6 months; Breast feeding is
must for nurishment.
• Good News : Covid +ve mothers can
breastfeed if they wish to do so.
• Practice respiratory hygiene, cover
mouth –nose, Wash hands; Routinely
clean, disinfect surfaces.
47
Breast Feeding : Covid +ve Mother :
• If Lactating mother is on Flabiflu, she should stop
Breast feeding and restart after 7 days of complete
flabiflu.
48
3. Doctors and Nurses to meet possible requirements
(beds do not treat patients)
4. Equipments, Medicines to meet more numbers;
PREPAREDNESS : THIRD WAVE
• Learnt from previous waves . .
• FOUR things are must :
1. Vaccination : safe surrounding to children
2. Medical Staff : Trained for covid care
49

More Related Content

What's hot

отчет корона
отчет коронаотчет корона
отчет коронаssuser7066e2
 
Amany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide resultsAmany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide resultsAmany Elshamy
 
COVID-19 Infection Prevention and Control (IPC)
COVID-19 Infection Prevention and Control (IPC)COVID-19 Infection Prevention and Control (IPC)
COVID-19 Infection Prevention and Control (IPC)Updesh Yadav
 
WEBINAR REPLAY: One Year On: COVID-19, Rapid Testing, Vaccines, and a Return ...
WEBINAR REPLAY: One Year On: COVID-19, Rapid Testing, Vaccines, and a Return ...WEBINAR REPLAY: One Year On: COVID-19, Rapid Testing, Vaccines, and a Return ...
WEBINAR REPLAY: One Year On: COVID-19, Rapid Testing, Vaccines, and a Return ...Charis Whitbourne
 
The covid 19- a mystery disease
The covid 19- a mystery diseaseThe covid 19- a mystery disease
The covid 19- a mystery diseaseBhoj Raj Singh
 
The importance of pertussis booster vaccine doses throughout life - Slideset ...
The importance of pertussis booster vaccine doses throughout life - Slideset ...The importance of pertussis booster vaccine doses throughout life - Slideset ...
The importance of pertussis booster vaccine doses throughout life - Slideset ...WAidid
 
FACTS ABOUT OMICRON WE SHOULD KNOW .......
FACTS ABOUT OMICRON WE SHOULD KNOW .......FACTS ABOUT OMICRON WE SHOULD KNOW .......
FACTS ABOUT OMICRON WE SHOULD KNOW .......MIND BLOWING
 
Corona virus mutation mechanism #SCIENCE_ADDA
Corona virus mutation mechanism #SCIENCE_ADDACorona virus mutation mechanism #SCIENCE_ADDA
Corona virus mutation mechanism #SCIENCE_ADDAscience adda
 
Safety and Preventive Measures during the Covid-19 Pandemic
Safety and Preventive Measures during the Covid-19 PandemicSafety and Preventive Measures during the Covid-19 Pandemic
Safety and Preventive Measures during the Covid-19 PandemicCognibrain Healthcare
 
swine flu , mexican ? 2009 Novel H1N1 pandemic !
swine flu , mexican ? 2009 Novel H1N1 pandemic ! swine flu , mexican ? 2009 Novel H1N1 pandemic !
swine flu , mexican ? 2009 Novel H1N1 pandemic ! Mona Youssef
 
Rapid testing for covid 19
Rapid testing for covid 19Rapid testing for covid 19
Rapid testing for covid 19David Ellis
 

What's hot (18)

отчет корона
отчет коронаотчет корона
отчет корона
 
All Business Briefing
All Business BriefingAll Business Briefing
All Business Briefing
 
Amany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide resultsAmany m. elshamy why the negative covid19 pcr test is a misguide results
Amany m. elshamy why the negative covid19 pcr test is a misguide results
 
COVID-19 Infection Prevention and Control (IPC)
COVID-19 Infection Prevention and Control (IPC)COVID-19 Infection Prevention and Control (IPC)
COVID-19 Infection Prevention and Control (IPC)
 
WEBINAR REPLAY: One Year On: COVID-19, Rapid Testing, Vaccines, and a Return ...
WEBINAR REPLAY: One Year On: COVID-19, Rapid Testing, Vaccines, and a Return ...WEBINAR REPLAY: One Year On: COVID-19, Rapid Testing, Vaccines, and a Return ...
WEBINAR REPLAY: One Year On: COVID-19, Rapid Testing, Vaccines, and a Return ...
 
The covid 19- a mystery disease
The covid 19- a mystery diseaseThe covid 19- a mystery disease
The covid 19- a mystery disease
 
The importance of pertussis booster vaccine doses throughout life - Slideset ...
The importance of pertussis booster vaccine doses throughout life - Slideset ...The importance of pertussis booster vaccine doses throughout life - Slideset ...
The importance of pertussis booster vaccine doses throughout life - Slideset ...
 
FACTS ABOUT OMICRON WE SHOULD KNOW .......
FACTS ABOUT OMICRON WE SHOULD KNOW .......FACTS ABOUT OMICRON WE SHOULD KNOW .......
FACTS ABOUT OMICRON WE SHOULD KNOW .......
 
Omicron variant
Omicron variantOmicron variant
Omicron variant
 
Corona virus mutation mechanism #SCIENCE_ADDA
Corona virus mutation mechanism #SCIENCE_ADDACorona virus mutation mechanism #SCIENCE_ADDA
Corona virus mutation mechanism #SCIENCE_ADDA
 
Omicron strain
Omicron strainOmicron strain
Omicron strain
 
Rota virus
Rota virusRota virus
Rota virus
 
Omicron variant
Omicron variantOmicron variant
Omicron variant
 
Safety and Preventive Measures during the Covid-19 Pandemic
Safety and Preventive Measures during the Covid-19 PandemicSafety and Preventive Measures during the Covid-19 Pandemic
Safety and Preventive Measures during the Covid-19 Pandemic
 
swine flu , mexican ? 2009 Novel H1N1 pandemic !
swine flu , mexican ? 2009 Novel H1N1 pandemic ! swine flu , mexican ? 2009 Novel H1N1 pandemic !
swine flu , mexican ? 2009 Novel H1N1 pandemic !
 
Covid-19 & Delta Variant Highlights from the Experts
Covid-19 & Delta Variant Highlights from the Experts Covid-19 & Delta Variant Highlights from the Experts
Covid-19 & Delta Variant Highlights from the Experts
 
Rapid testing for covid 19
Rapid testing for covid 19Rapid testing for covid 19
Rapid testing for covid 19
 
Omicron presentation
Omicron presentationOmicron presentation
Omicron presentation
 

Similar to Corona in children third wave

2020 unit 9 pandemics
2020 unit 9 pandemics2020 unit 9 pandemics
2020 unit 9 pandemicsRobert Cole
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UGamitakashyap1
 
Basic Concepts of PH
Basic Concepts of PHBasic Concepts of PH
Basic Concepts of PHamitakashyap1
 
Covid-19 Brief Review | A holistic review at pandemic
Covid-19 Brief Review | A holistic review at pandemic Covid-19 Brief Review | A holistic review at pandemic
Covid-19 Brief Review | A holistic review at pandemic Akhtar Hussain
 
The dynamics of disease transmission Dr Amita Kashyap
The dynamics of disease transmission Dr Amita KashyapThe dynamics of disease transmission Dr Amita Kashyap
The dynamics of disease transmission Dr Amita Kashyapamitakashyap1
 
EMERGING and RE-EMERGING DISEASES.pptx
EMERGING and RE-EMERGING DISEASES.pptxEMERGING and RE-EMERGING DISEASES.pptx
EMERGING and RE-EMERGING DISEASES.pptxAllen Rojer
 
Measles - Epidemiology and Control
Measles - Epidemiology and ControlMeasles - Epidemiology and Control
Measles - Epidemiology and ControlRizwan S A
 
COVID-19 ( A Report of 2019 )
COVID-19 ( A Report of 2019 )COVID-19 ( A Report of 2019 )
COVID-19 ( A Report of 2019 )VivekKumar3314
 
Dengue, Malaria, Chikungunya, Japanese Encephalitis, Pest Control.pptx
Dengue, Malaria, Chikungunya, Japanese Encephalitis, Pest Control.pptxDengue, Malaria, Chikungunya, Japanese Encephalitis, Pest Control.pptx
Dengue, Malaria, Chikungunya, Japanese Encephalitis, Pest Control.pptxYuvethaIndran
 
COVID19 PANDEMIC & UPSURGE OF OMICRON VARIANT
COVID19 PANDEMIC & UPSURGE OF OMICRON VARIANTCOVID19 PANDEMIC & UPSURGE OF OMICRON VARIANT
COVID19 PANDEMIC & UPSURGE OF OMICRON VARIANTSandeep Dogra
 
Dr hatem el bitar covid19 presention for pediatric
Dr hatem el bitar covid19 presention for pediatricDr hatem el bitar covid19 presention for pediatric
Dr hatem el bitar covid19 presention for pediatricد حاتم البيطار
 
Communicable diseases tb
Communicable diseases  tbCommunicable diseases  tb
Communicable diseases tbdrjagannath
 
Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.  Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis. AB Rajar
 
Covid19, varient overview
Covid19,  varient  overviewCovid19,  varient  overview
Covid19, varient overviewGagan Sharma
 
COVID-19 ORIENTATION Jan 2022-2.pptx
COVID-19 ORIENTATION Jan 2022-2.pptxCOVID-19 ORIENTATION Jan 2022-2.pptx
COVID-19 ORIENTATION Jan 2022-2.pptxPreetiSaini756391
 
covid-19 LECTURE-1.pptx
covid-19 LECTURE-1.pptxcovid-19 LECTURE-1.pptx
covid-19 LECTURE-1.pptxCollinsOrdu2
 

Similar to Corona in children third wave (20)

2020 unit 9 pandemics
2020 unit 9 pandemics2020 unit 9 pandemics
2020 unit 9 pandemics
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
 
Chikungunya
ChikungunyaChikungunya
Chikungunya
 
Basic Concepts of PH
Basic Concepts of PHBasic Concepts of PH
Basic Concepts of PH
 
Covid-19 Brief Review | A holistic review at pandemic
Covid-19 Brief Review | A holistic review at pandemic Covid-19 Brief Review | A holistic review at pandemic
Covid-19 Brief Review | A holistic review at pandemic
 
The dynamics of disease transmission Dr Amita Kashyap
The dynamics of disease transmission Dr Amita KashyapThe dynamics of disease transmission Dr Amita Kashyap
The dynamics of disease transmission Dr Amita Kashyap
 
Reboot after corona bombay chamber of commerce and industry
Reboot after corona bombay chamber of commerce and industryReboot after corona bombay chamber of commerce and industry
Reboot after corona bombay chamber of commerce and industry
 
EMERGING and RE-EMERGING DISEASES.pptx
EMERGING and RE-EMERGING DISEASES.pptxEMERGING and RE-EMERGING DISEASES.pptx
EMERGING and RE-EMERGING DISEASES.pptx
 
COVID-19 variant OMICRON
COVID-19 variant OMICRONCOVID-19 variant OMICRON
COVID-19 variant OMICRON
 
Measles - Epidemiology and Control
Measles - Epidemiology and ControlMeasles - Epidemiology and Control
Measles - Epidemiology and Control
 
COVID-19 ( A Report of 2019 )
COVID-19 ( A Report of 2019 )COVID-19 ( A Report of 2019 )
COVID-19 ( A Report of 2019 )
 
Dengue, Malaria, Chikungunya, Japanese Encephalitis, Pest Control.pptx
Dengue, Malaria, Chikungunya, Japanese Encephalitis, Pest Control.pptxDengue, Malaria, Chikungunya, Japanese Encephalitis, Pest Control.pptx
Dengue, Malaria, Chikungunya, Japanese Encephalitis, Pest Control.pptx
 
COVID19 PANDEMIC & UPSURGE OF OMICRON VARIANT
COVID19 PANDEMIC & UPSURGE OF OMICRON VARIANTCOVID19 PANDEMIC & UPSURGE OF OMICRON VARIANT
COVID19 PANDEMIC & UPSURGE OF OMICRON VARIANT
 
Dr hatem el bitar covid19 presention for pediatric
Dr hatem el bitar covid19 presention for pediatricDr hatem el bitar covid19 presention for pediatric
Dr hatem el bitar covid19 presention for pediatric
 
Dengue .pptx
Dengue .pptxDengue .pptx
Dengue .pptx
 
Communicable diseases tb
Communicable diseases  tbCommunicable diseases  tb
Communicable diseases tb
 
Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.  Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.
 
Covid19, varient overview
Covid19,  varient  overviewCovid19,  varient  overview
Covid19, varient overview
 
COVID-19 ORIENTATION Jan 2022-2.pptx
COVID-19 ORIENTATION Jan 2022-2.pptxCOVID-19 ORIENTATION Jan 2022-2.pptx
COVID-19 ORIENTATION Jan 2022-2.pptx
 
covid-19 LECTURE-1.pptx
covid-19 LECTURE-1.pptxcovid-19 LECTURE-1.pptx
covid-19 LECTURE-1.pptx
 

More from Dr. Rashmin Cecil

More from Dr. Rashmin Cecil (12)

Deficiency of Vitamin-C _Ascorbic acid_Pediatrics
Deficiency of Vitamin-C _Ascorbic acid_PediatricsDeficiency of Vitamin-C _Ascorbic acid_Pediatrics
Deficiency of Vitamin-C _Ascorbic acid_Pediatrics
 
B-complex B6 (Pyridoxine)
B-complex B6 (Pyridoxine)B-complex B6 (Pyridoxine)
B-complex B6 (Pyridoxine)
 
B-complex B7 (biotin)
B-complex B7 (biotin)B-complex B7 (biotin)
B-complex B7 (biotin)
 
B complex b3 niacin
B complex b3 niacinB complex b3 niacin
B complex b3 niacin
 
B-complex (b2 - Riboflavin)
B-complex  (b2 - Riboflavin)B-complex  (b2 - Riboflavin)
B-complex (b2 - Riboflavin)
 
B Complex (B1 Thiamine)
 B Complex  (B1 Thiamine) B Complex  (B1 Thiamine)
B Complex (B1 Thiamine)
 
Headache in children
Headache in childrenHeadache in children
Headache in children
 
Febrile seizures
Febrile seizuresFebrile seizures
Febrile seizures
 
Fever - Approach to Paediatric Patient
Fever - Approach to Paediatric PatientFever - Approach to Paediatric Patient
Fever - Approach to Paediatric Patient
 
Endocrine system
Endocrine systemEndocrine system
Endocrine system
 
Adrenal glands
Adrenal glandsAdrenal glands
Adrenal glands
 
Pancreas endocrine gland
Pancreas endocrine glandPancreas endocrine gland
Pancreas endocrine gland
 

Recently uploaded

Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...KokoStevan
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.MateoGardella
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfChris Hunter
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 

Recently uploaded (20)

Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 

Corona in children third wave

  • 1. 1
  • 2. :: INTRODUCTION :: • Many countries have restarted their normal routine after covid-19 pandemic. • While, some countries including India struggling with third wave of covid-19. • Third wave is out of understanding for laymen, and may do not accept this possibilities. • But, this third wave is predicted on scientific bases by scientific pannels, Medical experts and Global leaders.
  • 3. :: Pattern of Pandemic in population :: • Pandemics tend to occur in waves, and each wave causes a large number of cases. • Eventually, most of the population may get immune by Asymptomatic or Symptomatic infections (herd immunity). • Over a time disease may die out OR may become endemic in the community with low transmission rates.
  • 4. • Covid is caused by SARS CoV2 RNA Virus. This virus spreads from person to person. • As soon as it enters in human body, it starts process of its growth, and produce more numbers of similar viruses. • For that it contains RNA, on the basis of RNA it replicates many copies of it. :: What are waves in Pandemic? ORIGINAL VIRUS COPY-1 COPY-2 COPY-3 [1]
  • 5. 5 • But, in some cases it could not produce same copy of RNA, and it produce another type of virus. • This new virus is little different than the Original virus in characteristics. Because , its protein, spikes etc are changed. • Such new type of virus is called VARIANT. 5 :: What are waves in Pandemic? ORIGINAL VIRUS COPY-1 VARIANT-1 VARIANT-2 [2]
  • 6. 6 • The whole procedure is called mutation in scientific terms. • So many variants can be produce from one original virus. • Many types or variants are produced from Original (SARS CoV 2 -Wuhan) virus in the world. • Some variants are powerful, others are weak. Weak variants could not sustain for long time. • Variants which are more powerful for disease are known as variants of concern by WHO.
  • 7. • There are so many vaiants of concern identified so far; Alpha, Beta, gamma, delta etc. • Now a days Delta variant is in talk. • Delta variant found in India, during second wave, more damage caused by delta variant. • Now delta variant is found more than 98 countries in world. • The scientific name of delta variant is B 1.617.2
  • 8. According to WHO : • India has UK variant (Spreading in many states) • South Africa and Brazil variants (in some states) • Double mutant “B.1.618 ” in West Maharastra • Triple mutant “B.1.618” in west Bangal • There will be more due to huge turn over In fact the second wave is due to many variants and not due to the single variant of first wave. 8 Many variants are in India
  • 9. • Recently, scientist have found changes in Delta. The new variant of delta is K417N or Delta plus. • So, Detla plus, may have many differnt characteristics than Delta. • More than 40 cases are found in India, with new Delta plus variant. 9 Wave-2 by Delta . . Wave - 3 by ?? DELTA DELTA + DELTA + Caused Second WAVE May Cause Third WAVE ???
  • 10. 10 • Comparison for : Prediction for 3rd -Wave : • 1st Delta was found in Octo 2020. It is responsible for deadly second wave in India. • 1st case of Delta plus found on 5th April 2021. This variant may be cause for third wave in India. • The predictions of third wave are made by following Five factors. Comparision : Delta and Delta plus
  • 11. • These five points will help to predict about third wave 11 Delta and Delta plus variant : Transmissibility Virulence : 1 2 Test Compliant : 3 4 Drug Compliant : Vaccine Efficacy : 5 Delta+ is less transmissible than delta Ability to kill, Delta+ is less fatal than Delta Both identifiable with rapid and RTPCR Supportive drugs will work on both; Delta and Delta + effective on Delta, but Delta+ reduce rate up to 30%
  • 12. 12 • Mutants emerge if they have transmission advantage over predecessors. 1. A million a month vs a week tells us that all new variants are spreading 3-4 times faster than D614G varinat. 2. People and Government facilitated rapid dissemination of mutant variants by giving up on masks and physical distancing. 3. Eg. Kumbh mela (Jan -1 to April-20) and election rallies (February through April 1st week). 12 Why did infection spread so fast ?
  • 13. 13 13 • Epidemiology : Foundation Science of Public Health • In India, Epidemiology is used much in Research • Taught in Medical colleges and in schools of public health • Not used in health management, because there is no Public Health Infrastructure. • Destiny says : India Needs Public Health 13 Epidemiology : Who wants it ?
  • 14. 14 :: Ministry of Health :: 1 2 3 4 Dept of Health Services Dept of Family Welfare Dep of Health Research Missing Dept of Public Health India’s Ministry of Health has a Missing Elephant !!!!!
  • 15. 15 15 15 • A wave requires suffcient population • Left – over from 1st wave (700 million) plus 65,000 births per day : so . . . . . • 10 weeks . . . . . . Just 5 million children • Variants with greater RO emerged, Unnoticed • Failed to vaccinate at least 20-30 % of population to provide immune. • Encouraged crowding, avoid safety measures 15 Why did the Second wave emerged ? - 1
  • 16. 16 16 16 16 • 50% population was vulnerable after 1st wave • Left with D614G, There would not have been second wave, but new variants emerged. • The group of 10 labs (INSACOG) assigned for monitoring 5% of viruses for variant did not so • Entry of UK, south Africa and Brazil variants were unnoticed until 2nd wave emerged. • Indian Mutants (B.1.617 and 618) sperad fast in Maharastra and West Bengal 16 Why did the Second wave emerged ? - 2
  • 17. Attrributes of first wave : • Started : 06.03.2020; Peacked : 16.09.2020 (191 days) • Pre – Peak Cases : 5,115,893,(26,785/day) • Post-Peak Cases : 5,108,904 (49,124 / day) • End : 28.12.2020 (104 days) • Whole wave : 295 days (>42 weeks, ~ 10 months) • Cases : 10,224,791 (34,660 / day) • One Million Cases per month Rather symmetrical of bell-shaped . .
  • 18. 18 18 18 18 • Started : 09.03.2021 • Peaked : 06.05.2021 (58 days; ˃ 8 weeks) • Cases till peak : 10,240,661 (176563 / day) • Surge volume 176,563 / 26,785 = 6.6 times • Surge speed in days 191 / 58 = 3.3 times • One Million per 6 days • Time to reach million 30 / 6 = 5 times faster 18 :: Second Wave – Pre-peak Profile ::
  • 19. Around 23 African countries experienced third wave of COVID-19 as of July 13, 2021, according to CDC. 19
  • 20. 20
  • 21. • First wave : severe disease occurred - primarily - elderly and individuals with co-morbidities. • Second wave : Severe disease - younger group (30-45 years), also without co-morbidities. • If Third wave : likely to infect remaining non- immune individuals - include children also. • Latest sero-survey : infected children of 10-17 years was around 25%, the same as adults. • Children are as susceptible as adults and olders to develop infection but not severe disease. 21 Risk : Children and third Wave
  • 22. • 1st and 2nd wave make some population immune (herd immunity) • Some population immune by vaccines • Remaining part is unprotected : Children • No Vaccine > 18 yrs 22 WHY ? CHILDREN are at RISK ? • Census : • 41 % consist of < 18 years, it is large number • First wave : 1-2 % Children affected • Second wave : 10 % • Third wave : ??????
  • 23. • Coronaviruses can spread in Children by : • Parents and Elders are Major Source (Schools closed, children are at home only) 23 • After Second wave, sudden carelessnes by parents, children attended all functions with parents, gatherings etc. • Parents do not follow themselves or force Children for safety and precautions TRANSMISSION:
  • 24. • There are four stages for disease transmission: • Stage 1: Imported cases: • Disease is just introduced by traveled people . • Stage 2: Local transmission • Travelers spread infection : family, neighbors and friends. • Stage 3: Community transmission • Infection spreads in community in large areas. • Stage 4: Widespread outbreak or Epidemic stage • Fourth and Final stage of transmission, a widespread outbreak - an epidemic - as the number of cases and deaths begin rapidly multiplying, with no end in sight. STAGES OF TRANSMISSION:
  • 25. • Infection enters in body via following : 25 Portals of Entry : NOSE : EYES : 1 2 MOUTH : 3
  • 26. • Incubation Period is varied from person to person. • But average incubation period found is 2 to 15 days in recent cases. INCUBATION PERIOD :
  • 28. 28 Corona Virus Enters LUNGS Alveoli (2 types of cells in alveoli) Pneuomocyte type-1 Pneumocyte type-2 Helps for Gas exchange Produce surfactant Surfactant prevent lung from collapse Adhere Pneumocyte-2 ( S-Protein- ACE-2 Receptor ) PATHOGENESIS OF COVID -19 :: 1
  • 29. 29 Entry in Cells and replication APC(Antigen presenting Cell)- MHC Cytokine Storm Release of IL-1, IL-6 , TNF alpha Vasodilatation & Increased vascular Permeability PATHOGENESIS OF COVID -19 :: 2
  • 30. 30 Alveolar edema-Surfactant Dysregulation- Collapse of alveoli Hypoxia- Increased Work of Breathing MSOF –Multi system organ failure SIRS – Systemic Inflammatory Response Syndrome PATHOGENESIS OF COVID -19 :: 3
  • 31. Fever Dry cough Fatigue Running nose Body ache Headache Vomiting Anosmia : In ability to smell Ageusia : Inability to taste Abdominal related complaints Commom Clinical Features :
  • 32. 32 MILD CASES : 98% MODERATE CASES : 1 - 2 % SEVERE CASES : 0.5 - 1 % Spectrum : Disease severity in Children :
  • 33. 33 • Fever, Sore throat, rhinorrhoea, Cough, Diarrhoea, vomiting, Pain in abdomen, • Mild : Saturation > 94, • No tachypnoea, • No dehydration • Mild can be treated at home. • Home isolation Asymptomatic or Mild disease : [1]
  • 34. 34 • Fast Breathing (age based) : 1. < 2 months : > 60 / min 2. 2-12 months : > 50/min 3. 1-5 years : > 40/min 4. > 5 years : > 30/min • SPO2 : 90-94 % • No signs of severe illness (systemic involvement) • Moderate or severe dehydration Moderate disease (Pneumonia) : [2]
  • 35. • Pneumonia with any of the following : 1. Increased respiratory efforts (grunting, severe retractions) 2. (if speaking) Inability to complete full sentences 3. Cyanosis, SPO2 : less than 90 % 4. Letharty, somnolence, seizures, oliguria, • Keywords : Mild will never convert immediate severe, It will take time, identify it. 35 Severe illness, Severe pneumonia : [3]
  • 36. 1. ARDS : (Acute Respiratory Distress Syndrome), 2. Sepsis, Septic Shock, 3. MODS : (Multiple Organ dysfunction Syndrome), Thrombosis, 4. MIS-C : (Multi system inflammatory syndrome in Children) • Hospitalization : PICU, HDU(High Dependency Unit) 36 CRITICAL CONDITION :
  • 37. • COVID Suspect case: • Patient with ARI & or history of travel to a location of Community Transmission in last 14 days. • Pt with ARI & close contact with COVID pt in last 14 days • Or a pt with severe ARI in absence of alternative diagnosis • Probable case: • A suspected case with Test result inconclusive • or test could not be done yet, having some symptoms. • Confirmed case: • A Pt with positive COVID-19 test, even he do not have clinical signs and symptoms present. CLINICAL APPROACH :
  • 38. 1. RTPCR : If positive, do not confirm by CT Scan 2. RTPCR : CT value (cycle threshold) : less then 35 is significant : value, more than 35 is not covid positive : 3. Mild symptoms, Mild covid no other investigations required 4. CRP, D-dimer, HRCT etc should be decided by pediatrician DIAGNOSIS ::
  • 39. 1. Fever : PCM 10-15 mg/kg, repeat every 4-6 hours 2. Avoid NSAIDS (Ibuprofen, Mefenamic acid) 3. Cough suppressant : No role 4. Throat Soothing : Warm saline garlgles : only older children, adolescents 5. Antibiotics : not indicated 6. Adequet hydration, supportive care :: TREATMENT :: MILD DISEASE :: TREATMENT ::
  • 40. 40 1. Hospitalization : NO ICU needed 2. Monitor Progress 3. Feeding, fluid to avoid dehydration, over hydration 4. Antipyretics 5. Suspicion of bacterial infection : Amoxycillin 6. SPO2 < 94 % give O2 7. Rapid progression : steroids (by pediatrician) 8. Rare cases : Remdesivir (by pediatrician) :: TREATME MODERATE DISEASE TREATMENT
  • 41. 41 1. Intensive Care, PICU 2. ARDS, Sepsis, Septic shock, MIS-C 3. Investigations, Evaluate thrombosis, HLH organ failure, 4. Steroids, Remdesivir 5. Empiric Antimicrobials 6. Oxygen therapy 7. Restricted fluid therapy 8. Ventilation :: TREATME SEVERE DISEASE TREATMENT
  • 42. 42 • Following Children will required special care. Children : Requires Special Care : Congenital Heart Disease Kidney Diseases 1 2 Genetic diseases 3 4 Imminity Disorders Metabolic disorders 5
  • 43. 43 :: TREATME VACCINATION : PREVENTION • Develope Herd Immunity before 3rd wave. • Immune by disease or by Vaccination. First option is uncertain and may be fatal. Vaccination is safe and under our control. • Before third wave : atleast 40 % population must be vaccinated. • But unfortunately . . . . . . • In India 7.9 % people are fully vaccinated, • while 20.8 % are vaccinated for first dose.
  • 44. • This rate is much lower than other countries. 1. USA : 50.4 % 2. UK : 58.1 % 3. Israel : 59.5 % 4. Spain : 59.3 % 5. Canada : 60.7 % 6. India : 7.9 % • Source : http://www.mygov.in/information/covid-19 44 Vaccination : Worlwide :: (Fully )
  • 45. 45 :: TREATME GENERAL MEASURES PREVENTION 1. Above 2 years, Mask with three layers. 2. Less exposure to children, shopping, market, functions etc. 3. frequent Hand washing habit, personal sanitizer for them. 4. Adult, specially mothers should vaccinted, because children needs mother. 5. Identify symptoms in Children, Consult and follow Pediatrician.
  • 46. • Managing Children is More difficult : • Adult patient cooperate, follow instruction etc, can left alone with oxygen mask, etc • Children can not left alone, remove oxygen mask, needs care taker : • Limited Nurses, even can not sedate them • Only parents can manage : 24 hours • Parents sitting with them must Vaccinated !!! 46 Children : Hospitalization a Challange
  • 47. • less then 6 months; Breast feeding is must for nurishment. • Good News : Covid +ve mothers can breastfeed if they wish to do so. • Practice respiratory hygiene, cover mouth –nose, Wash hands; Routinely clean, disinfect surfaces. 47 Breast Feeding : Covid +ve Mother : • If Lactating mother is on Flabiflu, she should stop Breast feeding and restart after 7 days of complete flabiflu.
  • 48. 48 3. Doctors and Nurses to meet possible requirements (beds do not treat patients) 4. Equipments, Medicines to meet more numbers; PREPAREDNESS : THIRD WAVE • Learnt from previous waves . . • FOUR things are must : 1. Vaccination : safe surrounding to children 2. Medical Staff : Trained for covid care
  • 49. 49